...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Sotrastaurin, a new selective protein kinase C inhibitor, on the way.
【24h】

Sotrastaurin, a new selective protein kinase C inhibitor, on the way.

机译:一种新型的选择性蛋白激酶C抑制剂Sotrastaurin即将上市。

获取原文
获取原文并翻译 | 示例

摘要

The protein kinase Cs (PKCs), a family of serine-/ threonine-specific protein kinases, are involved in diverse signal transduction pathways that modulate a wide variety of cellular events including activation, proliferation, differentiation, apoptosis, and autophagy. To date, at least 10 isotypes of PKCs are known. They are divided into three subfamilies according to their structure and type of activation: classical/conventional PKCs (cPKC: alpha, betaI-II, and gamma) are diacylglycerol (DAG) and calcium-dependent enzymes, and novel PKCs (nPKC: delta, epsilon, eta, and theta) that require DAG, but not calcium, for activation.
机译:蛋白激酶Cs(PKCs)是丝氨酸/苏氨酸特异性蛋白激酶的一个家族,参与多种信号转导途径,调节多种细胞事件,包括激活,增殖,分化,凋亡和自噬。迄今为止,已知至少10种PKC同种型。根据其结构和激活类型将它们分为三个亚家族:经典/常规PKC(cPKC:α,βI-II和γ)是二酰基甘油(DAG)和钙依赖性酶,以及新型PKC(nPKC:δ,需要DAG而不是钙激活的epsilon,eta和theta)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号